Antioxidant Therapy Reduces Oxidative and Inflammatory Tissue Damage in Patients Subjected to Cardiac Surgery with Extracorporeal Circulation

Basic and Clinical Pharmacology and Toxicology

Volumn 108, Issue 4, 2011, Pages 256-262

  Castillo, Rodrigo ^a   Rodrigo, Ramón ^a   Perez, Felipe ^a   Cereceda, Mauricio ^b   Asenjo, René ^b   Zamorano, Jaime ^b   Navarrete, Roberto ^a   Villalabeitia, Eli ^c   Sanz, Juan ^c   Baeza, Cristián ^c   Aguayo, Rubén ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c HOSPITAL SAN JUAN DE DIOS   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; DNA; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; PLACEBO;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; DNA BINDING; ENZYME ACTIVATION; EXTRACORPOREAL CIRCULATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; OXIDATIVE STRESS; PNEUMOTHORAX; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RANDOMIZED CONTROLLED TRIAL; TISSUE INJURY; VITAMIN SUPPLEMENTATION;

AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; ASCORBIC ACID; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXTRACORPOREAL CIRCULATION; FATTY ACIDS, OMEGA-3; FEMALE; GLUTATHIONE DISULFIDE; HUMANS; INFLAMMATION; LIPID PEROXIDATION; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN CARBONYLATION; THORACIC SURGICAL PROCEDURES; VITAMIN E;

EID: 79952805607     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00651.x     Document Type: Article

References (33)

1. Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg 2009;88:326-33.
2. Ramlawi B, Out H, Mieno S, Boodhwani M, Sodha NR, Clements RT et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007;84:1166-73.
3. Cosgrave J, Foley JB, Flavin R, O'briain DS, Fitzpatrick E, Bennett K et al. Preoperative atrial histological changes are not associated with postoperative atrial fibrillation. Cardiovasc Pathol 2006;15:213-7.
4. Abdel-Rahman U, Risteski P, Tizi K, Kerscher S, Behjati S, Zwicker K et al. Hypoxic reoxygenation during initial reperfusion attenuates cardiac dysfunction and limits ischemia-reperfusion injury after cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg 2009;137:978-82.
5. Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study. Ann Card Anaesth 2009;12:127-32.
6. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-49.
7. Rodrigo R, Cereceda M, Castillo R, Asenjo R, Zamorano J, Araya J et al. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol Ther 2008;118:104-27.
8. Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005;45:1723-8.
9. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-26.
10. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-8.
11. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
12. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8.
13. Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. BioTechniques 1994;16:405.
14. Videla LA, Tapia G, Varela P, Cornejo P, Guerrero J, Israel Y et al. Effects of acute gamma-hexachlorocyclohexane intoxication in relation to the redox regulation of nuclear factor-kappaB, cytokine gene expression, and liver injury in the rat. Antioxid Redox Signal 2004;6:471-80.
15. Li J, Lai Y, Yeh H, Chen C, Sun S, Wu S et al. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation. Cardiology 2009;112:81-8.
16. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos J. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135-43.
17. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52:306-13.
18. Stanic B, Katsuyama M, Miller FJ Jr. An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol 2010;30:2234-41.
19. Sirker A, Zhang M, Murdoch C, Shah AM. Involvement of NADPH oxidases in cardiac remodelling and heart failure. Am J Nephrol 2007;27:649-60.
20. Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006;20:51-6.
21. Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillation. Cardiovasc Res 2002;54:247-58.
22. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005;79:1530-5.
23. Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010;3:46-53.
24. Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gottskalksson G et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 2010;12:356-63.
25. Shang LL, Sanyal S, Pfahnl AE, Jiao Z, Allen J, Liu H et al. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol 2008;294:C372-9.
26. Gao G, Dudley SC Jr. Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal 2009;11:2265-77.
27. Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H et al. Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007;282:28063-73.
28. Zhang H, Forman HJ. Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health 2009;25:269-78.
29. Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2007;282:2529-37.
30. Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009;91:791-5.
31. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids onserum markers of cardiovascular disease risk: asystematic review. Atherosclerosis 2006;189:19-30.
32. Ordovas J. Diet/genetic interactions and their effects on inflammatory markers. Nutr Rev 2007;65:S203-7.
33. Ulker S, McKeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534-9.